Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery by Gonzalez-Quintero, Victor Hugo, MD, MPH, Cordova, Yvette C., MD, Istwan, Niki B., RN, Tudela, Felipe, MD, Rhea, Debbie J., MPH, Romary, Letty Maria, MD, Marimon, Adrian, MD, Desch, Cheryl N., RN, MS, Stanziano, Gary J., MD

Get full text

Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter? by How, Helen Y., MD, Barton, John R., MD, Istwan, Niki B., RN, Rhea, Debbie J., MPH, Stanziano, Gary J., MD

Get full text

Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate by Rebarber, Andrei, MD, Ferrara, Lauren A., MD, Hanley, Maryellen L., MD, Istwan, Niki B., RN, Rhea, Debbie J., MPH, Stanziano, Gary J., MD, Saltzman, Daniel H., MD

Get full text

Elective delivery at 340/7 to 366/7 weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension by Barton, John R., MD, Barton, Lucy A., BS, Istwan, Niki B., RN, Desch, Cheryl N., MS, Rhea, Debbie J., MPH, Stanziano, Gary J., MD, Sibai, Baha M., MD

Get full text

Reply by Rebarber, Andrei, MD, Saltzman, Daniel, MD, Ferrara, Lauren A., MD, Istwan, Niki B., RN, Rhea, Debbie J., MPH, Stanziano, Gary J., MD, Hanley, MaryElllen, MD

Get full text